L. Ostrosky-zeichner, J. Rex, J. Bennett, and B. Kullberg, Deeply invasive candidiasis, Infectious Disease Clinics of North America, vol.16, issue.4, pp.821-856, 2002.
DOI : 10.1016/S0891-5520(02)00034-X

P. Pappas, C. Kauffman, D. Andes, D. Benjamin, T. Calandra et al., Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.48, issue.5, pp.503-538, 2009.
DOI : 10.1086/596757

B. Kullberg and M. Arendrup, Invasive Candidiasis, New England Journal of Medicine, vol.373, issue.15, pp.1445-56, 2015.
DOI : 10.1056/NEJMra1315399

P. Pappas, Invasive candidiasis Infect Dis Clin North Am, pp.485-506, 2006.

O. Leroy, J. Gangneux, P. Montravers, J. Mira, F. Gouin et al., Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France Crit Care Med, pp.1612-1620, 2005.

S. Ascioglu, J. Rex, B. Pauw, . De, J. Bennett et al., Defining Opportunistic Invasive Fungal Infections in Immunocompromised Patients with Cancer and Hematopoietic Stem Cell Transplants: An International Consensus, Clinical Infectious Diseases, vol.34, issue.1, pp.7-14, 2002.
DOI : 10.1086/323335

D. Poulain, Physiopathologie et diagnostic des candidoses systémiques. Lett Infect, pp.182-90, 2000.

M. Nucci and E. Anaissie, Revisiting the source of candidemia: skin or gut? Clin Infect Dis Off Publ Infect Dis Soc Am, pp.1959-67, 2001.

P. Eggimann, J. Bille, and O. Marchetti, Diagnosis of invasive candidiasis in the ICU. Ann Intensive Care, p.37, 2011.

Y. Magalhães, M. Bomfim, L. Melônio, P. Ribeiro, L. Cosme et al., Clinical significance of the isolation of Candida species from hospitalized patients, Brazilian Journal of Microbiology, vol.46, issue.1, pp.117-140, 2015.
DOI : 10.1590/S1517-838246120120296

P. Eggimann, J. Garbino, and D. Pittet, Epidemiology of Candida species infections in critically ill non-immunosuppressed patients, The Lancet Infectious Diseases, vol.3, issue.11, pp.685-702, 2003.
DOI : 10.1016/S1473-3099(03)00801-6

M. Develoux and S. Bretagne, Candidoses et levuroses diverses, EMC-Mal Infect, pp.1-15, 2005.

P. Charles, F. Dalle, A. H. Doise, J. Quenot, J. Aho et al., Candida spp. colonization significance in critically ill medical patients: a prospective study, Intensive Care Medicine, vol.36, issue.3, pp.393-400, 2005.
DOI : 10.1007/s00134-005-2571-y

F. Marco, S. Lockhart, M. Pfaller, C. Pujol, M. Rangel-frausto et al., Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3, J Clin Microbiol, vol.37, issue.9, pp.2817-2845, 1999.

N. Gow, F. Van-de-veerdonk, A. Brown, and M. Netea, Candida albicans morphogenesis and host defence: discriminating invasion from colonization, Nature Reviews Microbiology, vol.139, 2012.
DOI : 10.1016/j.cell.2009.09.033

M. Arendrup, Epidemiology of invasive candidiasis, Current Opinion in Critical Care, vol.16, issue.5, pp.445-52, 2010.
DOI : 10.1097/MCC.0b013e32833e84d2

A. Cleveland, L. Harrison, M. Farley, R. Hollick, B. Stein et al., Declining Incidence of Candidemia and the Shifting Epidemiology of Candida Resistance in Two US Metropolitan Areas, 2008???2013: Results from Population-Based Surveillance, PLOS ONE, vol.85, issue.1, p.120452, 2015.
DOI : 10.1371/journal.pone.0120452.t002

D. Bitar, O. Lortholary, L. Strat, Y. Nicolau, J. Coignard et al., Population-based analysis of invasive fungal infections, Emerg Infect Dis. 2014, vol.20, issue.7, pp.1149-55, 2001.

R. Hajjeh, A. Sofair, L. Harrison, G. Lyon, B. Arthington-skaggs et al., Incidence of Bloodstream Infections Due to Candida Species and In Vitro Susceptibilities of Isolates Collected from 1998 to 2000 in a Population-Based Active Surveillance Program, Journal of Clinical Microbiology, vol.42, issue.4, 2004.
DOI : 10.1128/JCM.42.4.1519-1527.2004

D. Bitar, O. Lortholary, F. Dromer, B. Coignard, and C. D. , Mycoses invasives en France métropolitaine : incidence, létalité et tendance, Bull Épidémiologique Hebd, pp.12-13109, 2001.

O. Lortholary, C. Renaudat, K. Sitbon, Y. Madec, L. Denoeud-ndam et al., Worrisome trends in incidence and mortality of candidemia in intensive care units (Paris area Intensive Care Med, pp.1303-1315, 2002.

H. Wisplinghoff, T. Bischoff, S. Tallent, H. Seifert, R. Wenzel et al., Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.309-326, 2004.

D. Kett, E. Azoulay, P. Echeverria, and J. Vincent, Extended Prevalence of Infection in ICU Study (EPIC II) Group of Investigators. Candida bloodstream infections in intensive care units: analysis of the extended prevalence of infection in intensive care unit study, Crit Care Med, 2011.

E. Gürcüo?lu, H. Akal?n, B. Ener, G. Ocako?lu, M. S?n?rta? et al., Nosocomial candidemia in adults: Risk and prognostic factors, Journal de Mycologie M??dicale, vol.20, issue.4, pp.269-78, 2010.
DOI : 10.1016/j.mycmed.2010.07.006

A. Tabah, D. Koulenti, K. Laupland, B. Misset, J. Valles et al., Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study, Intensive Care Medicine, vol.378, issue.12, pp.1930-1975, 2012.
DOI : 10.1016/S0140-6736(11)60401-7

J. Vincent, J. Rello, J. Marshall, E. Silva, A. Anzueto et al., International Study of the Prevalence and Outcomes of Infection in Intensive Care Units, JAMA, vol.302, issue.21, pp.2323-2332, 2009.
DOI : 10.1001/jama.2009.1754

O. Marchetti, J. Bille, U. Fluckiger, P. Eggimann, C. Ruef et al., Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, Clin Infect Dis Off Publ Infect Dis Soc Am Feb, vol.138, issue.3, pp.311-331, 1991.

M. Méan, O. Marchetti, and C. T. , Bench-to-bedside review: Candida infections in the intensive care unit, Critical Care, vol.12, issue.1, p.204, 2008.
DOI : 10.1186/cc6212

J. Quenot, C. Binquet, F. Kara, O. Martinet, F. Ganster et al., The epidemiology of septic shock in French intensive care units: the prospective multicenter cohort EPISS study. Crit Care Lond Engl The epidemiology of candidemia in two United States cities: results of a population-based active surveillance, pp.1164-70, 1999.
URL : https://hal.archives-ouvertes.fr/inserm-00873494

K. Gradel, H. Schønheyder, M. Arpi, J. Knudsen, C. Ostergaard et al., The Danish Collaborative Bacteraemia Network (DACOBAN) database, Clinical Epidemiology, vol.6, pp.301-309, 2014.
DOI : 10.2147/CLEP.S66998

S. Magill, J. Edwards, W. Bamberg, Z. Beldavs, G. Dumyati et al., Multistate Point-Prevalence Survey of Health Care???Associated Infections, New England Journal of Medicine, vol.370, issue.13, pp.1198-208, 2014.
DOI : 10.1056/NEJMoa1306801

R. Hobson, The global epidemiology of invasive Candida infections?is the tide turning? J Hosp Infect, pp.159-68, 2003.

N. Yapar, Epidemiology and risk factors for invasive candidiasis, Therapeutics and Clinical Risk Management, vol.10, pp.95-105, 2014.
DOI : 10.2147/TCRM.S40160

J. Talarmin, D. Boutoille, P. Tattevin, S. Dargère, P. Weinbreck et al., ??pid??miologie des candid??mies??: ??tude observationnelle prospective d???un an dans l???Ouest de la France, M??decine et Maladies Infectieuses, vol.39, issue.12, pp.877-85, 2009.
DOI : 10.1016/j.medmal.2009.02.008

T. Tigen, E. Bilgin, H. , P. Gurun, H. Dogru et al., Risk factors, characteristics, and outcomes of candidemia in an adult intensive care unit in Turkey Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting, Am J Infect Control Eur J Clin Microbiol Infect Dis, vol.3726, issue.4, pp.271-277, 2007.

M. Arendrup, S. Sulim, A. Holm, L. Nielsen, S. Nielsen et al., Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia, Journal of Clinical Microbiology, vol.49, issue.9, 2011.
DOI : 10.1128/JCM.00179-11

M. Martínez, E. , A. García, A. Martín-mazuelos, and E. , Epidemiology, risk factors and in vitro susceptibility in candidaemia due to non-Candida albicans species], Rev Iberoam Micol, 2016.

M. Falagas, K. Apostolou, and V. Pappas, Attributable mortality of candidemia: a systematic review of matched cohort and case-control studies, European Journal of Clinical Microbiology & Infectious Diseases, vol.38, issue.7, pp.419-444, 2006.
DOI : 10.1164/ajrccm.160.3.9808145

M. Bassetti, E. Righi, F. Ansaldi, M. Merelli, C. Trucchi et al., A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality, Intensive Care Med, 2014.

M. Puig-asensio, B. Padilla, J. Garnacho-montero, O. Zaragoza, J. Aguado et al., Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain, Clinical Microbiology and Infection, vol.20, issue.4, pp.245-254
DOI : 10.1111/1469-0691.12380

S. Giuliano, M. Guastalegname, A. Russo, M. Falcone, V. Ravasio et al., endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis, Expert Review of Anti-infective Therapy, vol.54, issue.4, pp.807-825, 2017.
DOI : 10.1016/S0735-1097(00)01206-7

M. Bassetti, E. Righi, F. Ansaldi, M. Merelli, C. Scarparo et al., A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality, Intensive Care Medicine, vol.45, issue.1, pp.1601-1611, 2015.
DOI : 10.1128/JCM.00131-07

Y. Ha, K. Peck, E. Joo, S. Kim, S. Jung et al., Impact of First-Line Antifungal Agents on the Outcomes and Costs of Candidemia, Antimicrobial Agents and Chemotherapy, vol.56, issue.7, pp.3950-3956
DOI : 10.1128/AAC.06258-11

C. Trouvé, S. Blot, M. Hayette, S. Jonckheere, S. Patteet et al., Epidemiology and reporting of candidaemia in Belgium: a multi-centre study, European Journal of Clinical Microbiology & Infectious Diseases, vol.34, issue.3, 2016.
DOI : 10.1007/s10096-015-2322-0

D. Francesco, M. Piccinelli, G. Gelmi, M. Gargiulo, F. Ravizzola et al., Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years, Mycopathologia, vol.28, issue.50, 2017.
DOI : 10.1097/QCO.0000000000000215

S. Tedeschi, F. Tumietto, M. Giannella, M. Bartoletti, F. Cristini et al., Epidemiology and outcome of candidemia in internal medicine wards: A regional study in Italy, European Journal of Internal Medicine, vol.34, pp.39-44, 2016.
DOI : 10.1016/j.ejim.2016.08.020

M. Richardson and C. Lass-flörl, Changing epidemiology of systemic fungal infections, Clinical Microbiology and Infection, vol.14, issue.4, pp.5-24, 2008.
DOI : 10.1111/j.1469-0691.2008.01978.x

I. Das, P. Nightingale, M. Patel, and P. Jumaa, Epidemiology, clinical characteristics, and outcome of candidemia: experience in a tertiary referral center in the UK, International Journal of Infectious Diseases, vol.15, issue.11, pp.759-763, 2011.
DOI : 10.1016/j.ijid.2011.06.006

D. Enoch, H. Ludlam, and N. Brown, Invasive fungal infections: a review of epidemiology and management options, Journal of Medical Microbiology, vol.55, issue.7, pp.809-827, 2006.
DOI : 10.1099/jmm.0.46548-0

J. Guinea, Ó. Zaragoza, P. Escribano, E. Martín-mazuelos, J. Pemán et al., Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011, Antimicrobial Agents and Chemotherapy, vol.58, issue.3, pp.1529-1566, 2010.
DOI : 10.1128/AAC.02155-13

M. Pfaller, D. Diekema, D. Gibbs, V. Newell, D. Ellis et al., Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion, Journal of Clinical Microbiology, vol.48, issue.4, pp.1366-77, 1997.
DOI : 10.1128/JCM.02117-09

S. Lockhart, N. Iqbal, A. Cleveland, M. Farley, L. Harrison et al., Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011, Journal of Clinical Microbiology, vol.50, issue.11, pp.3435-3477, 2008.
DOI : 10.1128/JCM.01283-12

M. Nucci, F. Queiroz-telles, A. Tobón, A. Restrepo, and A. Colombo, Epidemiology of opportunistic fungal infections in Latin America. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.561-70, 2010.

M. Nucci, F. Queiroz-telles, T. Alvarado-matute, I. Tiraboschi, J. Cortes et al., Epidemiology of Candidemia in Latin America: A Laboratory-Based Survey, PLoS ONE, vol.55, issue.1981, p.59373, 2013.
DOI : 10.1371/journal.pone.0059373.t005

M. Bassetti, M. Molinari, M. Mussap, C. Viscoli, and E. Righi, Candidaemia in internal medicine departments: the burden of a rising problem, Clinical Microbiology and Infection, vol.19, issue.6, pp.281-284
DOI : 10.1111/1469-0691.12155

M. Bassetti, M. Merelli, E. Righi, A. Diaz-martin, E. Rosello et al., Epidemiology, Species Distribution, Antifungal Susceptibility, and Outcome of Candidemia across Five Sites in Italy and Spain, Journal of Clinical Microbiology, vol.51, issue.12, pp.4167-72, 2013.
DOI : 10.1128/JCM.01998-13

M. Pfaller and D. Diekema, Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem, Clinical Microbiology Reviews, vol.20, issue.1, pp.133-63, 2007.
DOI : 10.1128/CMR.00029-06

O. Lortholary, C. Renaudat, K. Sitbon, M. Desnos-ollivier, S. Bretagne et al., The risk and clinical outcome of candidemia depending on underlying malignancy. Intensive Care Med, 2017.

E. Playford, D. Marriott, Q. Nguyen, S. Chen, D. Ellis et al., Candidemia in nonneutropenic critically ill patients: Risk factors for non-albicans Candida spp., Critical Care Medicine, vol.36, issue.7, pp.2034-2043, 2008.
DOI : 10.1097/CCM.0b013e3181760f42

G. Dimopoulos, F. Ntziora, G. Rachiotis, A. Armaganidis, M. Falagas et al., Candida albicans versus nonalbicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth Analg Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit, Feb, vol.10646, issue.638, pp.523-5291206, 2008.

A. Ullmann, O. Cornely, J. Donnelly, M. Akova, M. Arendrup et al., ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.18, pp.1-8, 2012.

O. Cornely, M. Bassetti, C. T. Garbino, J. Kullberg, B. Lortholary et al., ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.18, pp.19-37, 2012.

M. Cuenca-estrella, P. Verweij, M. Arendrup, S. Arikan-akdagli, J. Bille et al., ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures, Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis, vol.18, issue.7, pp.9-18, 2012.

M. Arendrup, T. Horn, and N. Frimodt-møller, In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model, Infection, vol.30, issue.5, pp.286-91, 2002.
DOI : 10.1007/s15010-002-2131-0

C. Vaz, P. Sampaio, K. Clemons, Y. Huang, D. Stevens et al., Microsatellite multilocus genotyping clarifies the relationship of Candida parapsilosis strains involved in a neonatal intensive care unit outbreak, Diagnostic Microbiology and Infectious Disease, vol.71, issue.2, pp.159-62, 2011.
DOI : 10.1016/j.diagmicrobio.2011.05.014

T. Plantinga, M. Johnson, W. Scott, E. Van-de-vosse, V. Edwards et al., Toll-like Receptor 1 Polymorphisms Increase Susceptibility to Candidemia, The Journal of Infectious Diseases, vol.205, issue.6, pp.934-977, 2012.
DOI : 10.1093/infdis/jir867

V. Kumar, S. Cheng, M. Johnson, S. Smeekens, A. Wojtowicz et al., Immunochip SNP array identifies novel genetic variants conferring susceptibility to candidaemia, Nature Communications, vol.37, p.4675, 2014.
DOI : 10.1038/ng1617

URL : https://hal.archives-ouvertes.fr/hal-01064610

B. Kullberg, F. Van-de-veerdonk, and M. Netea, Immunotherapy, Current Opinion in Infectious Diseases, vol.27, issue.6, pp.511-517, 2014.
DOI : 10.1097/QCO.0000000000000105

J. Hoffmann, F. Kafatos, C. Janeway, and R. Ezekowitz, Phylogenetic Perspectives in Innate Immunity, Science, vol.284, issue.5418, pp.1313-1321, 1999.
DOI : 10.1126/science.284.5418.1313

P. Pappas, C. Kauffman, D. Andes, C. Clancy, K. Marr et al., Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.62, issue.4, pp.409-426, 2016.
DOI : 10.1093/cid/civ1194

C. Clancy and M. Nguyen, Finding the ???Missing 50%??? of Invasive Candidiasis: How Nonculture Diagnostics Will Improve Understanding of Disease Spectrum and Transform Patient Care, Clinical Infectious Diseases, vol.56, issue.9, pp.1284-92, 2013.
DOI : 10.1093/cid/cit006

M. Morrell, V. Fraser, and M. Kollef, Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality, Antimicrobial Agents and Chemotherapy, vol.49, issue.9, pp.3640-3645, 2005.
DOI : 10.1128/AAC.49.9.3640-3645.2005

K. Garey, M. Rege, M. Pai, D. Mingo, K. Suda et al., Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.25-31, 2006.

A. Kumar, D. Roberts, K. Wood, B. Light, J. Parrillo et al., Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock*, Critical Care Medicine, vol.34, issue.6, pp.1589-96, 2006.
DOI : 10.1097/01.CCM.0000217961.75225.E9

M. Garrouste-orgeas, J. Timsit, M. Tafflet, B. Misset, J. Zahar et al., Excess Risk of Death from Intensive Care Unit--Acquired Nosocomial Bloodstream Infections: A Reappraisal, Clinical Infectious Diseases, vol.42, issue.8, pp.1118-1144, 2006.
DOI : 10.1086/500318

M. Kollef, S. Micek, N. Hampton, J. Doherty, and A. Kumar, Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control, Clinical Infectious Diseases, vol.54, issue.12, pp.1739-1785
DOI : 10.1093/cid/cis305

M. Fernández-ruiz, M. Puig-asensio, J. Guinea, B. Almirante, B. Padilla et al., Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance, Journal of Infection, vol.71, issue.3, pp.385-94, 2015.
DOI : 10.1016/j.jinf.2015.05.009

M. Puig-asensio, B. Padilla, J. Garnacho-montero, O. Zaragoza, J. Aguado et al., Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: a population-based surveillance in Spain, Clinical Microbiology and Infection, vol.20, issue.4, pp.245-254
DOI : 10.1111/1469-0691.12380

E. Azoulay, H. Dupont, A. Tabah, O. Lortholary, J. Stahl et al., Systemic antifungal therapy in critically ill patients without invasive fungal infection*. Crit Care Med, pp.813-835, 2012.

L. Ostrosky-zeichner, S. Shoham, J. Vazquez, A. Reboli, R. Betts et al., MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting, Clinical Infectious Diseases, vol.58, issue.9, pp.1219-1245, 2014.
DOI : 10.1093/cid/ciu074

S. Magill, S. Swoboda, E. Johnson, W. Merz, R. Pelz et al., The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients, Diagnostic Microbiology and Infectious Disease, vol.55, issue.4, pp.293-301, 2006.
DOI : 10.1016/j.diagmicrobio.2006.03.013

D. Pittet, M. Monod, P. Suter, E. Frenk, and R. Auckenthaler, Candida Colonization and Subsequent Infections in Critically III Surgical Patients, Annals of Surgery, vol.220, issue.6, pp.751-759, 1994.
DOI : 10.1097/00000658-199412000-00008

R. Piarroux, F. Grenouillet, P. Balvay, V. Tran, G. Blasco et al., Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients(*), Critical Care Medicine, vol.32, issue.12, pp.2443-2452, 2004.
DOI : 10.1097/01.CCM.0000147726.62304.7F

C. León, S. Ruiz-santana, P. Saavedra, B. Galván, A. Blanco et al., Usefulness of the ???Candida score??? for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study, Critical Care Medicine, vol.37, issue.5, pp.1624-1657, 2009.
DOI : 10.1097/CCM.0b013e31819daa14

C. León, S. Ruiz-santana, P. Saavedra, B. Almirante, J. Nolla-salas et al., A bedside scoring system (???Candida score???) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization*, Critical Care Medicine, vol.34, issue.3, pp.730-737, 2006.
DOI : 10.1097/01.CCM.0000202208.37364.7D

M. Bougnoux, G. Kac, P. Aegerter, C. Enfert, J. Fagon et al., Candidemia and candiduria in critically ill patients admitted to intensive care units in France: incidence, molecular diversity, management and outcome, Intensive Care Medicine, vol.36, issue.2, pp.292-301, 2008.
DOI : 10.1093/infdis/168.1.195

E. Azoulay, J. Timsit, M. Tafflet, A. De-lassence, M. Darmon et al., Candida Colonization of the Respiratory Tract and Subsequent Pseudomonas Ventilator-Associated Pneumonia, Chest, vol.129, issue.1, pp.110-117, 2006.
DOI : 10.1378/chest.129.1.110

P. Eggimann and D. Pittet, Candida colonization index and subsequent infection in critically ill surgical patients: 20??years later, Intensive Care Medicine, vol.42, issue.Suppl 7, pp.1429-1477, 2014.
DOI : 10.1097/CCM.0000000000000208

G. Leroy, F. Lambiotte, D. Thévenin, C. Lemaire, E. Parmentier et al., Evaluation of 'Candida score' in critically ill patients: a prospective, multicenter, observational, cohort study. Ann Intensive Care, p.50, 2011.

G. Gaspar, M. Menegueti, M. Auxiliadora-martins, A. Basile-filho, and R. Martinez, Evaluation of the predictive indices for candidemia in an adult intensive care unit. Rev Soc Bras Med Trop, 2015.

M. Khlif, H. Sellami, A. Sellami, F. Makni, F. Cheikhrouhou et al., Detection and identification of Candida sp. by PCR in candidemia diagnosis, Journal de Mycologie M??dicale, vol.17, issue.4, pp.256-60, 2007.
DOI : 10.1016/j.mycmed.2007.10.001

F. Lamoth, M. Cruciani, C. Mengoli, E. Castagnola, O. Lortholary et al., ?-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3) Clin Infect Dis Off Publ Infect Dis Soc Am, pp.633-676, 2012.

M. Mikulska, C. T. Sanguinetti, M. Poulain, D. Viscoli, and C. , The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia, Third European Conference on Infections in Leukemia Group, p.222, 2010.
DOI : 10.1128/CVI.00200-08

URL : https://hal.archives-ouvertes.fr/inserm-00663709

M. Arendrup, T. Boekhout, M. Akova, J. Meis, O. Cornely et al., ESCMID??? and ECMM??? joint clinical guidelines for the diagnosis and management of rare invasive yeast infections, Clinical Microbiology and Infection, vol.20, pp.76-98
DOI : 10.1111/1469-0691.12360

C. Sims, S. Jaijakul, J. Mohr, J. Rodriguez, M. Finkelman et al., Correlation of Clinical Outcomes with ??-Glucan Levels in Patients with Invasive Candidiasis, Journal of Clinical Microbiology, vol.50, issue.6, 2012.
DOI : 10.1128/JCM.00773-12

D. Karageorgopoulos, E. Vouloumanou, F. Ntziora, A. Michalopoulos, P. Rafailidis et al., ?-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.750-70, 2011.

M. Bassetti, M. Marchetti, A. Chakrabarti, S. Colizza, J. Garnacho-montero et al., A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts, Intensive Care Medicine, vol.46, issue.3, pp.2092-106, 2013.
DOI : 10.1128/JCM.02091-07

C. León, L. Ostrosky-zeichner, and M. Schuster, What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients. Intensive Care Med, pp.808-827, 2014.

J. Mohr, C. Sims, V. Paetznick, J. Rodriguez, M. Finkelman et al., Prospective Survey of (1->3)-??-D-Glucan and Its Relationship to Invasive Candidiasis in the Surgical Intensive Care Unit Setting, Journal of Clinical Microbiology, vol.49, issue.1, pp.58-61, 2011.
DOI : 10.1128/JCM.01240-10

B. Posteraro, D. Pascale, G. Tumbarello, M. Torelli, R. Pennisi et al., Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1???3)-??-D-glucan assay, Candida score, and colonization index, Critical Care, vol.15, issue.5, p.249, 2011.
DOI : 10.1007/s10096-004-1104-x

D. Bono, V. Delfino, E. Furfaro, E. Mikulska, M. Nicco et al., Clinical Performance of the (1,3)-??-D-Glucan Assay in Early Diagnosis of Nosocomial Candida Bloodstream Infections, Clinical and Vaccine Immunology, vol.18, issue.12, pp.2113-2120, 2011.
DOI : 10.1128/CVI.05408-11

C. León, S. Ruiz-santana, P. Saavedra, C. Castro, A. Ubeda et al., Value of ??-d-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions, Intensive Care Medicine, vol.54, issue.8, 2012.
DOI : 10.1093/cid/cis200

F. Tissot, F. Lamoth, P. Hauser, C. Orasch, U. Flückiger et al., ??-Glucan Antigenemia Anticipates Diagnosis of Blood Culture???Negative Intraabdominal Candidiasis, American Journal of Respiratory and Critical Care Medicine, vol.34, issue.9, pp.1100-1109, 2013.
DOI : 10.1371/journal.pone.0042282

K. Hanson, C. Pfeiffer, E. Lease, A. Balch, A. Zaas et al., ??-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study, PLoS ONE, vol.7, issue.8, p.42282, 2012.
DOI : 10.1371/journal.pone.0042282.s002

E. Martín-mazuelos, A. Loza, C. Castro, D. Macías, I. Zakariya et al., ??-d-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis, Intensive Care Medicine, vol.16, issue.Suppl 1, pp.1424-1456, 2015.
DOI : 10.1128/CVI.00183-09

J. Poissy, B. Sendid, S. Damiens, I. Ishibashi, K. François et al., Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation, Critical Care, vol.18, issue.3, p.135, 2014.
DOI : 10.1097/CCM.0b013e31819daa14

J. Pemán, R. Zaragoza, G. Quindós, M. Alkorta, M. Cuétara et al., Clinical factors associated with a Candida albicansGerm Tube Antibody positive test in Intensive Care Unit patients, BMC Infectious Diseases, vol.34, issue.1, p.60, 2009.
DOI : 10.1097/01.CCM.0000202435.98240.ED

M. Martínez-jiménez, P. Muñoz, M. Valerio, R. Alonso, C. Martos et al., Candida biomarkers in patients with candidaemia and bacteraemia, J Antimicrob Chemother, 2015.

J. Held, I. Kohlberger, E. Rappold, B. Grawitz, A. Häcker et al., Comparison of (1->3)-??-D-Glucan, Mannan/Anti-Mannan Antibodies, and Cand-Tec Candida Antigen as Serum Biomarkers for Candidemia, Journal of Clinical Microbiology, vol.51, issue.4, pp.1158-64
DOI : 10.1128/JCM.02473-12

M. Martínez-jiménez, P. Muñoz, M. Valerio, A. Vena, J. Guinea et al., Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment, J Antimicrob Chemother, 2015.

T. Avni, L. Leibovici, and M. Paul, PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis, Journal of Clinical Microbiology, vol.49, issue.2, pp.665-70, 2011.
DOI : 10.1128/JCM.01602-10

M. Nguyen, M. Wissel, R. Shields, M. Salomoni, B. Hao et al., Performance of Candida Real-time Polymerase Chain Reaction, ??-D-Glucan Assay, and Blood Cultures in the Diagnosis of Invasive Candidiasis, Clinical Infectious Diseases, vol.54, issue.9, 2012.
DOI : 10.1093/cid/cis200

J. Fortún, Y. Meije, M. Buitrago, S. Gago, L. Bernal-martinez et al., Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients, Journal of Antimicrobial Chemotherapy, vol.69, issue.11, pp.3134-3175, 2014.
DOI : 10.1093/jac/dku225

S. Chang, W. Hsieh, T. Liu, S. Lee, C. Wang et al., Multiplex PCR System for Rapid Detection of Pathogens in Patients with Presumed Sepsis ??? A Systemic Review and Meta-Analysis, PLoS ONE, vol.224, issue.5, p.62323, 2013.
DOI : 10.1371/journal.pone.0062323.s003

E. Mylonakis, C. Clancy, L. Ostrosky-zeichner, K. Garey, G. Alangaden et al., T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial, Clinical Infectious Diseases, vol.60, issue.6, pp.892-901, 2015.
DOI : 10.1093/cid/ciu959

D. Andes, N. Safdar, J. Baddley, G. Playford, A. Reboli et al., Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials, Clinical Infectious Diseases, vol.54, issue.8, pp.1110-1132
DOI : 10.1093/cid/cis021

M. Puig-asensio, J. Pemán, R. Zaragoza, J. Garnacho-montero, E. Martín-mazuelos et al., Impact of Therapeutic Strategies on the Prognosis of Candidemia in the ICU*, Critical Care Medicine, vol.42, issue.6, pp.1423-1455
DOI : 10.1097/CCM.0000000000000221

M. Schuster, J. Edwards, J. Sobel, R. Darouiche, A. Karchmer et al., Empirical Fluconazole versus Placebo for Intensive Care Unit Patients, Annals of Internal Medicine, vol.149, issue.2, pp.83-90, 2008.
DOI : 10.7326/0003-4819-149-2-200807150-00004

R. Bruyère, J. Quenot, S. Prin, F. Dalle, C. Vigneron et al., Empirical antifungal therapy with an echinocandin in critically-ill patients: prospective evaluation of a pragmatic Candida score-based strategy in one medical ICU, BMC Infectious Diseases, vol.7, issue.8, p.385, 2014.
DOI : 10.1371/journal.pone.0042282

E. Playford, . J. Lipman, M. Kabir, E. Mcbryde, G. Nimmo et al., Assessment of clinical risk predictive rules for invasive candidiasis in a prospective multicentre cohort of ICU patients, Intensive Care Medicine, vol.55, issue.12, pp.2141-2146, 2009.
DOI : 10.1007/s00134-009-1619-9

J. Timsit, E. Azoulay, M. Cornet, J. Gangneux, V. Jullien et al., EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial, Trials, vol.14, issue.1, p.399, 2013.
DOI : 10.1093/jac/dkr394

URL : https://hal.archives-ouvertes.fr/inserm-00913515

B. Alexander, M. Johnson, C. Pfeiffer, C. Jiménez-ortigosa, J. Catania et al., Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations, Clinical Infectious Diseases, vol.56, issue.12, pp.1724-1756, 2013.
DOI : 10.1093/cid/cit136

N. Beyda, J. John, A. Kilic, M. Alam, T. Lasco et al., FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.819-844, 2014.

R. Shields, M. Nguyen, E. Press, C. Updike, and C. Clancy, Caspofungin MICs Correlate with Treatment Outcomes among Patients with Candida glabrata Invasive Candidiasis and Prior Echinocandin Exposure, Antimicrobial Agents and Chemotherapy, vol.57, issue.8, pp.3528-3563, 2013.
DOI : 10.1128/AAC.00136-13

B. Walker, M. Powers-fletcher, R. Schmidt, and K. Hanson, Cost-Effectiveness Analysis of Multiplex PCR with Magnetic Resonance Detection versus Empiric or Blood Culture-Directed Therapy for Management of Suspected Candidemia, Journal of Clinical Microbiology, vol.54, issue.3, pp.718-744, 2016.
DOI : 10.1128/JCM.02971-15

J. Rex, J. Bennett, A. Sugar, P. Pappas, C. Van-der-horst et al., A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia, New England Journal of Medicine, vol.331, issue.20, pp.1325-1355, 1994.
DOI : 10.1056/NEJM199411173312001

J. Mora-duarte, R. Betts, C. Rotstein, A. Colombo, L. Thompson-moya et al., Comparison of Caspofungin and Amphotericin B for Invasive Candidiasis, New England Journal of Medicine, vol.347, issue.25, pp.2020-2029, 2002.
DOI : 10.1056/NEJMoa021585

B. Kullberg, J. Sobel, M. Ruhnke, P. Pappas, C. Viscoli et al., Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial, The Lancet, vol.366, issue.9495, pp.1435-1477, 2005.
DOI : 10.1016/S0140-6736(05)67490-9

E. Kuse, P. Chetchotisakd, C. Da-cunha, M. Ruhnke, C. Barrios et al., Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial, The Lancet, vol.369, issue.9572, pp.1519-1546, 2007.
DOI : 10.1016/S0140-6736(07)60605-9

P. Pappas, C. Rotstein, R. Betts, M. Nucci, D. Talwar et al., Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.883-93, 2007.

A. Reboli, C. Rotstein, P. Pappas, S. Chapman, D. Kett et al., Anidulafungin versus Fluconazole for Invasive Candidiasis, New England Journal of Medicine, vol.356, issue.24, pp.2472-82, 2007.
DOI : 10.1056/NEJMoa066906

A. Reboli, A. Shorr, C. Rotstein, P. Pappas, D. Kett et al., Anidulafungin compared with fluconazole for treatment of candidemia and other forms of invasive candidiasis caused by Candida albicans: a multivariate analysis of factors associated with improved outcome, BMC Infectious Diseases, vol.17, issue.Suppl 1, p.261, 2011.
DOI : 10.1016/0732-8893(93)90020-8

G. Eschenauer, P. Carver, S. Lin, K. Klinker, Y. Chen et al., Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study, Journal of Antimicrobial Chemotherapy, vol.68, issue.4, pp.922-928
DOI : 10.1093/jac/dks482

M. Ruhnke, J. Paiva, W. Meersseman, J. Pachl, I. Grigoras et al., Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients, Clinical Microbiology and Infection, vol.18, issue.7, pp.680-687
DOI : 10.1111/j.1469-0691.2012.03784.x

J. Vazquez, A. Reboli, P. Pappas, T. Patterson, J. Reinhardt et al., Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial, BMC Infectious Diseases, vol.46, issue.Suppl 7, p.97, 2014.
DOI : 10.1128/JCM.00566-08

M. Johnson, C. Macdougall, L. Ostrosky-zeichner, J. Perfect, and J. Rex, Combination Antifungal Therapy, Antimicrobial Agents and Chemotherapy, vol.48, issue.3, pp.693-715, 2004.
DOI : 10.1128/AAC.48.3.693-715.2004

M. Sinnollareddy, S. Peake, M. Roberts, . J. Lipman, and J. Roberts, Using pharmacokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: a systematic review, International Journal of Antimicrobial Agents, vol.39, issue.1, pp.1-10
DOI : 10.1016/j.ijantimicag.2011.07.013

J. Rex, P. Pappas, A. Karchmer, J. Sobel, J. Edwards et al., A Randomized and Blinded Multicenter Trial of High???Dose Fluconazole plus Placebo versus Fluconazole plus Amphotericin B as Therapy for Candidemia and Its Consequences in Nonneutropenic Subjects, Clinical Infectious Diseases, vol.36, issue.10, pp.1221-1229, 2003.
DOI : 10.1086/374850

O. Lashof, A. Donnelly, J. Meis, J. Van-der-meer, J. Kullberg et al., Duration of antifungal treatment and development of delayed complications in patients with candidaemia

M. Nucci, E. Anaissie, R. Betts, B. Dupont, C. Wu et al., Early Removal of Central Venous Catheter in Patients with Candidemia Does Not Improve Outcome: Analysis of 842 Patients from 2 Randomized Clinical Trials, Clinical Infectious Diseases, vol.51, issue.3, pp.295-303, 2010.
DOI : 10.1086/653935

D. Horn, L. Ostrosky-zeichner, M. Morris, A. Ullmann, C. Wu et al., Factors related to survival and treatment success in invasive candidiasis or candidemia: a pooled analysis of two large, prospective, micafungin trials, European Journal of Clinical Microbiology & Infectious Diseases, vol.45, issue.2, pp.223-232, 2010.
DOI : 10.3201/eid0908.030069

E. Brass and J. Edwards, Should the guidelines for management of central venous catheters in patients with candidemia be changed now? Clin Infect Dis Off Publ Infect Dis Soc Am, pp.304-310, 2010.

O. Lortholary, M. Desnos-ollivier, K. Sitbon, A. Fontanet, S. Bretagne et al., Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients, Antimicrobial Agents and Chemotherapy, vol.55, issue.2, 2011.
DOI : 10.1128/AAC.01128-10

URL : https://hal.archives-ouvertes.fr/hal-00818523

D. Shah, R. Yau, T. Lasco, J. Weston, M. Salazar et al., Impact of Prior Inappropriate Fluconazole Dosing on Isolation of Fluconazole-Nonsusceptible Candida Species in Hospitalized Patients with Candidemia, Antimicrobial Agents and Chemotherapy, vol.56, issue.6, pp.3239-3282
DOI : 10.1128/AAC.00019-12

S. Park, R. Kelly, J. Kahn, J. Robles, M. Hsu et al., Specific Substitutions in the Echinocandin Target Fks1p Account for Reduced Susceptibility of Rare Laboratory and Clinical Candida sp. Isolates, Antimicrobial Agents and Chemotherapy, vol.49, issue.8, pp.3264-73, 2005.
DOI : 10.1128/AAC.49.8.3264-3273.2005

M. Arendrup and D. Perlin, Echinocandin resistance, Current Opinion in Infectious Diseases, vol.27, issue.6, pp.484-92, 2014.
DOI : 10.1097/QCO.0000000000000111

U. Klotz, D. Schmidt, B. Willinger, E. Steinmann, J. Buer et al., isolates from two university hospitals in Germany and Austria, Mycoses, vol.54, issue.5, pp.312-320, 2016.
DOI : 10.1128/AAC.00836-10

M. Bougnoux, E. Dannaoui, I. Accoceberry, A. Angoulvant, E. Bailly et al., Multicenter Comparison of the Etest and EUCAST Methods for Antifungal Susceptibility Testing of Candida Isolates to Micafungin, Antimicrobial Agents and Chemotherapy, vol.60, issue.8, pp.5088-91, 2016.
DOI : 10.1128/AAC.00630-16

URL : https://hal.archives-ouvertes.fr/hal-01367142

M. Pfaller, M. Castanheira, S. Lockhart, A. Ahlquist, S. Messer et al., Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata, Journal of Clinical Microbiology, vol.50, issue.4, pp.1199-203
DOI : 10.1128/JCM.06112-11

R. Shields, M. Nguyen, E. Press, and C. Clancy, Abdominal Candidiasis Is a Hidden Reservoir of Echinocandin Resistance, Antimicrobial Agents and Chemotherapy, vol.58, issue.12, pp.7601-7606, 2014.
DOI : 10.1128/AAC.04134-14

L. Siri, P. Legarraga, P. García, T. González, and R. Rabagliati, Clinical and epidemiological changes of candidemia among adult patients from 2000 to 2013]. Rev Chil Infectologia Organo Of Soc Chil Infectologia, Feb, vol.34, issue.1, pp.19-26, 2017.

H. Wang, N. Liu, M. Yin, H. Han, J. Yue et al., The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study, BMC Infectious Diseases, vol.58, issue.Suppl 1, p.609, 2014.
DOI : 10.1016/j.jinf.2008.12.008

S. Veen, . Van, E. Claas, and E. Kuijper, High-Throughput Identification of Bacteria and Yeast by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Conventional Medical Microbiology Laboratories, Journal of Clinical Microbiology, vol.48, issue.3, pp.900-907, 2010.
DOI : 10.1128/JCM.02071-09

A. Ghosh, S. Paul, P. Sood, S. Rudramurthy, A. Rajbanshi et al., Matrix-assisted laser desorption ionization time-of-flight mass spectrometry for the rapid identification of yeasts causing bloodstream infections, Clinical Microbiology and Infection, vol.21, issue.4, pp.372-380
DOI : 10.1016/j.cmi.2014.11.009

N. Dhiman, L. Hall, S. Wohlfiel, S. Buckwalter, and N. Wengenack, Performance and Cost Analysis of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Routine Identification of Yeast, Journal of Clinical Microbiology, vol.49, issue.4, pp.1614-1620, 2011.
DOI : 10.1128/JCM.02381-10

M. Pfaller, M. Castanheira, D. Diekema, S. Messer, G. Moet et al., Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species, Journal of Clinical Microbiology, vol.48, issue.5, pp.1592-1601, 2010.
DOI : 10.1128/JCM.02445-09

M. Pfaller and D. Diekema, Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012, Journal of Clinical Microbiology, vol.50, issue.9, pp.2846-56, 2012.
DOI : 10.1128/JCM.00937-12

M. Arendrup, E. Dzajic, R. Jensen, H. Johansen, P. Kjaeldgaard et al., Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme, Clinical Microbiology and Infection, vol.19, issue.8, pp.343-353, 2013.
DOI : 10.1111/1469-0691.12212

L. Tadec, J. Talarmin, T. Gastinne, C. Bretonnière, M. Miegeville et al., Epidemiology, risk factor, species distribution, antifungal resistance and outcome of Candidemia at a single French hospital: a 7-year study, Mycoses, vol.18, issue.5, pp.296-303, 2016.
DOI : 10.1111/1469-0691.12038

M. Bassetti, M. Merelli, F. Ansaldi, D. De-florentiis, A. Sartor et al., Clinical and Therapeutic Aspects of Candidemia: A Five Year Single Centre Study, PLOS ONE, vol.54, issue.8, p.127534, 2015.
DOI : 10.1371/journal.pone.0127534.t005

A. Cleveland, M. Farley, L. Harrison, B. Stein, R. Hollick et al., Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011, Clinical Infectious Diseases, vol.55, issue.10, pp.1352-61, 2008.
DOI : 10.1093/cid/cis697

S. Arias, O. Denis, I. Montesinos, S. Cherifi, M. Deyi et al., Epidemiology and mortality of candidemia both related and unrelated to the central venous catheter: a retrospective cohort study, European Journal of Clinical Microbiology & Infectious Diseases, vol.49, issue.3, pp.501-508, 2017.
DOI : 10.2307/1937887

M. Sasso, C. Roger, M. Sasso, H. Poujol, S. Barbar et al., spp. isolates, antifungal drug consumption and susceptibility in a French intensive care unit: A 10-year study, Mycoses, vol.56, issue.13, 2017.
DOI : 10.1128/AAC.00355-12

M. Pfaller, S. Messer, G. Moet, R. Jones, and M. Castanheira, Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008???2009), International Journal of Antimicrobial Agents, vol.38, issue.1, pp.65-74, 2008.
DOI : 10.1016/j.ijantimicag.2011.02.016

E. Meyer, C. Geffers, P. Gastmeier, and F. Schwab, No increase in primary nosocomial candidemia in 682 German intensive care units during, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.18, issue.24, 2006.

M. Caira, A. Candoni, L. Verga, A. Busca, M. Delia et al., Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study), Haematologica, vol.100, issue.2, pp.284-92, 2015.
DOI : 10.3324/haematol.2014.113399

O. Cornely, B. Gachot, H. Akan, M. Bassetti, O. Uzun et al., Epidemiology and outcome of fungemia in a cancer Cohort of the Infectious Diseases Group (IDG) of the European Organization for Research and Treatment of Cancer (EORTC 65031) Clin Infect Dis Off Publ Infect Dis Soc Am, pp.324-355, 2015.

L. Pagano, G. Dragonetti, C. Cattaneo, F. Marchesi, B. Veggia et al., Changes in the incidence of candidemia and related mortality in patients with hematologic malignancies in the last ten years. A SEIFEM 2015-B report, Haematologica, vol.102, issue.10, pp.407-417, 2017.
DOI : 10.3324/haematol.2017.172536

T. Patterson, G. Thompson, D. Denning, J. Fishman, S. Hadley et al., Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America, Clinical Infectious Diseases, vol.63, issue.4, pp.1-60, 2016.
DOI : 10.1093/cid/ciw326

A. Prigitano, C. Cavanna, M. Passera, C. Ossi, E. Sala et al., CAND-LO 2014???15 study: changing epidemiology of candidemia in Lombardy (Italy), Infection, vol.33, issue.6, pp.765-80, 2016.
DOI : 10.1007/s10096-014-2096-9

R. Luzzati, S. Cavinato, M. Giangreco, G. Granà, S. Centonze et al., Peripheral and total parenteral nutrition as the strongest risk factors for nosocomial candidemia in elderly patients: a matched case-control study, Mycoses, vol.87, issue.6, pp.664-71, 2013.
DOI : 10.1016/S0002-9343(89)80392-4

M. Guastalegname, A. Russo, M. Falcone, S. Giuliano, and M. Venditti, Candidemia Subsequent to Severe Infection Due to Clostridium difficile: Is There a Link? Clin Infect Dis [Internet] Available from: http://paperity.org/p/42773222/candidemia- subsequent-to-severe-infection-due-to-clostridium-difficile-is-there-a-link, 2013.

A. Russo, M. Falcone, M. Fantoni, R. Murri, L. Masucci et al., Risk factors and clinical outcomes of candidaemia in patients treated for Clostridium difficile infection, Clinical Microbiology and Infection, vol.21, issue.5, pp.493-494, 2015.
DOI : 10.1016/j.cmi.2014.12.024

M. Papadimitriou-olivgeris, A. Spiliopoulou, F. Fligou, P. Manolopoulou, I. Spiliopoulou et al., Association of KPC-producing Klebsiella pneumoniae colonization or infection with Candida isolation and selection of non-albicans species, Diagnostic Microbiology and Infectious Disease, vol.80, issue.3, 2014.
DOI : 10.1016/j.diagmicrobio.2014.07.012

A. Ramos-martínez, N. Vicente-lópez, I. Sánchez-romero, B. Padilla, P. Merino-amador et al., Epidemiology and prognosis of candidaemia in elderly patients. Mycoses, 2017.

J. Guinea, Global trends in the distribution of Candida species causing candidemia, Clinical Microbiology and Infection, vol.20, issue.6, pp.5-10
DOI : 10.1111/1469-0691.12539

M. Falagas, N. Roussos, and K. Vardakas, Relative frequency of albicans and the various nonalbicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review, Int J Infect Dis IJID Off Publ Int Soc Infect Dis, vol.14, issue.11, pp.954-966, 2010.

M. Arendrup, B. Bruun, J. Christensen, K. Fuursted, H. Johansen et al., National Surveillance of Fungemia in Denmark (2004 to 2009), Journal of Clinical Microbiology, vol.49, issue.1, pp.325-359, 2004.
DOI : 10.1128/JCM.01811-10

N. Sipsas, R. Lewis, J. Tarrand, R. Hachem, K. Rolston et al., Candidemia in patients with hematologic malignancies in the era of new antifungal agents): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer, pp.4745-52, 1920.

C. Chen, S. Huang, W. Tsay, M. Yao, J. Tang et al., Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001???2010, International Journal of Antimicrobial Agents, vol.40, issue.6, pp.533-541, 2001.
DOI : 10.1016/j.ijantimicag.2012.07.022

S. Dufresne, K. Marr, E. Sydnor, J. Staab, J. Karp et al., Epidemiology of Candida kefyr in Patients with Hematologic Malignancies, Journal of Clinical Microbiology, vol.52, issue.6, pp.1830-1837
DOI : 10.1128/JCM.00131-14

J. Guinea, Global trends in the distribution of Candida species causing candidemia, Clinical Microbiology and Infection, vol.20, issue.6, pp.5-10
DOI : 10.1111/1469-0691.12539

D. Al, Drug-Resistant Candida glabrata Infection in Cancer Patients Number 11?November 2014 -Emerging Infectious Disease journal -CDC. [cited 2017 Oct 15]; Available from: https://wwwnc.cdc.gov/eid/article, pp.14-0685

B. Tan, A. Chakrabarti, R. Li, A. Patel, S. Watcharananan et al., Incidence and species distribution of candidaemia in Asia: a laboratory-based surveillance study, Clinical Microbiology and Infection, vol.21, issue.10, pp.946-53, 2015.
DOI : 10.1016/j.cmi.2015.06.010

F. Dalle, I. Lafon, L. 'ollivier, C. Ferrant, E. Sicard et al., A prospective analysis of the genotypic diversity and dynamics of the Candida albicans colonizing flora in neutropenic patients with de novo acute leukemia, Haematologica, vol.93, issue.4, pp.581-588, 2008.
DOI : 10.3324/haematol.11882

M. Pfaller, D. Neofytos, D. Diekema, N. Azie, H. Meier-kriesche et al., Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance??) registry, 2004???2008, Diagnostic Microbiology and Infectious Disease, vol.74, issue.4, pp.323-354, 2004.
DOI : 10.1016/j.diagmicrobio.2012.10.003

D. Horn, D. Neofytos, E. Anaissie, J. Fishman, W. Steinbach et al., Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis Off Publ Infect Dis Soc Am, pp.1695-703, 2009.

E. Blanchard, O. Lortholary, K. Boukris-sitbon, M. Desnos-ollivier, F. Dromer et al., Prior Caspofungin Exposure in Patients with Hematological Malignancies Is a Risk Factor for Subsequent Fungemia Due to Decreased Susceptibility in Candida spp.: a Case-Control Study in Paris, France, Antimicrobial Agents and Chemotherapy, vol.55, issue.11, pp.5358-61, 2011.
DOI : 10.1128/AAC.00690-11

URL : https://hal.archives-ouvertes.fr/hal-00818510

P. Fournier, C. Schwebel, D. Maubon, A. Vesin, B. Lebeau et al., Antifungal use influences Candida species distribution and susceptibility in the intensive care unit, Journal of Antimicrobial Chemotherapy, vol.66, issue.12, pp.2880-2886, 2011.
DOI : 10.1093/jac/dkr394

URL : https://hal.archives-ouvertes.fr/hal-00818509

M. Pfaller, Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment, The American Journal of Medicine, vol.125, issue.1, pp.3-13
DOI : 10.1016/j.amjmed.2011.11.001

D. Sanglard and F. Odds, Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences, The Lancet Infectious Diseases, vol.2, issue.2, pp.73-85, 2002.
DOI : 10.1016/S1473-3099(02)00181-0

F. Morio, F. Pagniez, M. Besse, F. Gay-andrieu, M. Miegeville et al., Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans, International Journal of Antimicrobial Agents, vol.42, issue.5, pp.410-415, 2013.
DOI : 10.1016/j.ijantimicag.2013.07.013

A. Coste, A. Selmecki, A. Forche, D. Diogo, M. Bougnoux et al., Genotypic Evolution of Azole Resistance Mechanisms in Sequential Candida albicans Isolates. Eukaryot Cell, 2007.

M. Castanheira, L. Deshpande, A. Davis, P. Rhomberg, and M. Pfaller, ABSTRACT, Antimicrobial Agents and Chemotherapy, vol.61, issue.10, 2017.
DOI : 10.1128/AAC.00906-17

W. Resistance, Available from, Global Report on Surveillance. [Internet], pp.62-66, 2014.

A. Panackal, J. Gribskov, J. Staab, K. Kirby, M. Rinaldi et al., Clinical Significance of Azole Antifungal Drug Cross-Resistance in Candida glabrata, Journal of Clinical Microbiology, vol.44, issue.5, pp.1740-1743, 2006.
DOI : 10.1128/JCM.44.5.1740-1743.2006

F. Barchiesi, E. Orsetti, P. Osimani, C. Catassi, F. Santelli et al., Factors related to outcome of bloodstream infections due to Candida parapsilosis complex, BMC Infectious Diseases, vol.45, issue.1, p.387, 2009.
DOI : 10.1086/520980

D. Diekema, S. Messer, L. Boyken, R. Hollis, J. Kroeger et al., In Vitro Activity of Seven Systemically Active Antifungal Agents against a Large Global Collection of Rare Candida Species as Determined by CLSI Broth Microdilution Methods, Journal of Clinical Microbiology, vol.47, issue.10, 2009.
DOI : 10.1128/JCM.00942-09

L. Marcos-zambrano, M. Gómez-perosanz, P. Escribano, E. Bouza, and J. Guinea, The novel oral glucan synthase inhibitor SCY-078 shows in vitro activity against sessile and planktonic Candida spp., Journal of Antimicrobial Chemotherapy, vol.72, issue.7, pp.1969-76, 2017.
DOI : 10.1093/jac/dkx010

D. Perlin, Mechanisms of echinocandin antifungal drug resistance, Annals of the New York Academy of Sciences, vol.333, issue.Suppl 7, pp.1-11
DOI : 10.1126/science.1206412

M. Lackner, M. Tscherner, M. Schaller, K. Kuchler, C. Mair et al., Positions and Numbers of FKS Mutations in Candida albicans Selectively Influence In Vitro and In Vivo Susceptibilities to Echinocandin Treatment, Antimicrobial Agents and Chemotherapy, vol.58, issue.7, pp.3626-3661
DOI : 10.1128/AAC.00123-14

J. Lewis, N. Wiederhold, B. Wickes, T. Patterson, and J. Jorgensen, Rapid Emergence of Echinocandin Resistance in Candida glabrata Resulting in Clinical and Microbiologic Failure, Antimicrobial Agents and Chemotherapy, vol.57, issue.9, pp.4559-61, 2013.
DOI : 10.1128/AAC.01144-13

S. Vallabhaneni, A. Cleveland, M. Farley, L. Harrison, W. Schaffner et al., Epidemiology and Risk Factors for Echinocandin Nonsusceptible Candida glabrata Bloodstream Infections: Data From a Large Multisite Population-Based Candidemia Surveillance Program Available from: https, Open Forum Infect Dis, vol.2, issue.4, 2008.

M. Arendrup, D. Perlin, R. Jensen, S. Howard, J. Goodwin et al., Differential In Vivo Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without FKS Resistance Mutations, Antimicrobial Agents and Chemotherapy, vol.56, issue.5, pp.2435-2477, 2012.
DOI : 10.1128/AAC.06369-11

R. Shields, M. Nguyen, E. Press, R. Cumbie, E. Driscoll et al., Mutations among Consecutive Candida Isolates Causing Bloodstream Infection, Antimicrobial Agents and Chemotherapy, vol.59, issue.12, pp.7465-70, 2015.
DOI : 10.1128/AAC.01973-15

R. Shields, M. Nguyen, E. Press, A. Kwa, S. Cheng et al., The Presence of an FKS Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata, Antimicrobial Agents and Chemotherapy, vol.56, issue.9, pp.4862-4871, 2012.
DOI : 10.1128/AAC.00027-12

K. Healey, Y. Zhao, W. Perez, S. Lockhart, J. Sobel et al., Prevalent mutator genotype identified in fungal pathogen Candida glabrata promotes multi-drug resistance, Nature Communications, vol.3, p.11128, 2016.
DOI : 10.1111/j.1365-2958.2012.08194.x

R. Jensen, H. Johansen, L. Søes, L. Lemming, F. Rosenvinge et al., Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study, Antimicrobial Agents and Chemotherapy, vol.60, issue.3, pp.1500-1508, 2016.
DOI : 10.1128/AAC.01763-15

S. Vallabhaneni, A. Kallen, S. Tsay, N. Chow, R. Welsh et al., Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus- United States, Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg, vol.17, issue.1, pp.2017296-2017305, 2013.

A. Fekkar, I. Meyer, J. Brossas, E. Dannaoui, M. Palous et al., Rapid Emergence of Echinocandin Resistance during Candida kefyr Fungemia Treatment with Caspofungin, Antimicrobial Agents and Chemotherapy, vol.57, issue.5, pp.2380-2382
DOI : 10.1128/AAC.02037-12

S. Asner, S. Giulieri, M. Diezi, O. Marchetti, and D. Sanglard, Acquired Multidrug Antifungal Resistance in Candida lusitaniae during Therapy, Antimicrobial Agents and Chemotherapy, vol.59, issue.12, pp.7715-7737, 2015.
DOI : 10.1128/AAC.02204-15

M. Pfaller, D. Diekema, D. Gibbs, V. Newell, E. Nagy et al., Candida krusei, a Multidrug-Resistant Opportunistic Fungal Pathogen: Geographic and Temporal Trends from the ARTEMIS DISK Antifungal Surveillance Program, J Clin Microbiol, 2001.

R. Hirano, Y. Sakamoto, K. Kudo, and M. Ohnishi, Retrospective analysis of mortality and Candida isolates of 75 patients with candidemia: a single hospital experience. Infect Drug Resist, pp.199-205, 2015.

A. Gupta, A. Gupta, and A. Varma, Candida glabrata candidemia: An emerging threat in critically ill patients. Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med, 2015.

E. Anaissie, J. Rex, O. Uzun, and S. Vartivarian, Predictors of Adverse Outcome in Cancer Patients with Candidemia 11Supported by a grant from Pfizer Pharmaceuticals, Inc., The American Journal of Medicine, vol.104, issue.3, pp.238-283, 1998.
DOI : 10.1016/S0002-9343(98)00030-8

I. Raad, H. Hanna, M. Boktour, E. Girgawy, H. Danawi et al., Management of Central Venous Catheters in Patients with Cancer and Candidemia, Clinical Infectious Diseases, vol.38, issue.8, pp.1119-1146, 2004.
DOI : 10.1086/382874

B. Almirante, D. Rodríguez, B. Park, M. Cuenca-estrella, A. Planes et al., Epidemiology and Predictors of Mortality in Cases of Candida Bloodstream Infection: Results from Population-Based Surveillance, Barcelona, Spain, from 2002 to 2003, Journal of Clinical Microbiology, vol.43, issue.4, pp.1829-1864, 2002.
DOI : 10.1128/JCM.43.4.1829-1835.2005

G. Kumar, N. Kumar, A. Taneja, T. Kaleekal, S. Tarima et al., Nationwide Trends of Severe Sepsis in the 21st Century (2000???2007), Chest, vol.140, issue.5, pp.1223-1254, 2000.
DOI : 10.1378/chest.11-0352

T. Williams, K. Ho, G. Dobb, J. Finn, M. Knuiman et al., Changes in case-mix and outcomes of critically ill patients in an Australian tertiary intensive care unit. Anaesth Intensive Care, pp.703-712, 2010.

D. Gaieski, J. Edwards, M. Kallan, and B. Carr, Benchmarking the Incidence and Mortality of Severe Sepsis in the United States*, Critical Care Medicine, vol.41, issue.5, pp.1167-74, 2013.
DOI : 10.1097/CCM.0b013e31827c09f8

E. Stevenson, A. Rubenstein, G. Radin, R. Wiener, and A. Walkey, Two Decades of Mortality Trends Among Patients With Severe Sepsis, Critical Care Medicine, vol.42, issue.3, 2014.
DOI : 10.1097/CCM.0000000000000026